Immune-checkpoint reporter cell line


Cancer immunotherapy has demonstrated impressive clinical benefit evidenced by PD1 antibodies and IDO inhibitors. We provide immune-checkpoint reporter cell line to accelerate immunotherapy discovery and development.

Example:


OX40 Reporter Cell Line


Primary T Cell Assay-OX40 Antibody